Jan 5 (Reuters) - Prometic Life Sciences Inc PLI.TO :
* Prometic reacquires plasminogen rights from Hematech
* Prometic Life Sciences Inc - regains 100 pct ownership of profits from future sales of plasminogen for congenital deficiency
* Prometic Life Sciences Inc - hematech continues to hold taiwanese rights to ppps as cmo supplier to prometic
* Prometic Life Sciences Inc - consideration for acquiring rights included issuance of 1.7 million shares of prometic to Hematech
* Prometic Life Sciences Inc - amended its licensing agreement originally entered into with Hematech Biotherapeutics Inc in May 2012
* Prometic Life Sciences Inc - consideration included payment of mid-single digit royalty as well as other non-cash considerations to license agreement Source text for Eikon: ID:nCNWmFmqka Further company coverage: PLI.TO